Koshinski Asset Management Inc. Purchases 507 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Defense World Staff on Jun 24th, 2023

Koshinski Asset Management Inc. lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 4.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,294 shares of the healthcare conglomerate’s stock after buying an additional 507 shares during the quarter. Koshinski Asset Management Inc.’s holdings in UnitedHealth Group were worth $6,283,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Chelsea Counsel Co. bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $27,000. Freedom Wealth Alliance LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $31,000. Investors Research Corp raised its stake in UnitedHealth Group by 51.1% during the 4th quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 24 shares during the period. Legend Financial Advisors Inc. purchased a new position in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Finally, Bourgeon Capital Management LLC grew its holdings in UnitedHealth Group by 192.3% during the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $40,000 after buying an additional 50 shares in the last quarter. Institutional investors own 92.61% of the company’s stock.

UnitedHealth Group Trading Down 0.4 %

Shares of NYSE UNH opened at $477.00 on Friday. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.71. The business has a fifty day simple moving average of $485.19 and a two-hundred day simple moving average of $492.64. The firm has a market cap of $444.10 billion, a PE ratio of 21.81, a price-to-earnings-growth ratio of 1.34 and a beta of 0.68. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last issued its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. The business had revenue of $91.93 billion during the quarter, compared to analyst estimates of $89.77 billion. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. UnitedHealth Group’s revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the company posted $5.49 EPS. Analysts expect that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.58%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date is Thursday, June 15th. UnitedHealth Group’s payout ratio is presently 34.39%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on UNH. Piper Sandler began coverage on UnitedHealth Group in a report on Thursday, May 25th. They set an “overweight” rating and a $580.00 price target for the company. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $627.00 to $564.00 in a report on Friday, June 16th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Monday, April 17th. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Tuesday, February 28th. Finally, StockNews.com cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $592.68.

Insider Transactions at UnitedHealth Group

In other news, CEO Andrew Witty sold 6,160 shares of the business’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CEO Andrew Witty sold 6,160 shares of the business’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,684 shares of the business’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $488.46, for a total value of $822,566.64. Following the transaction, the executive vice president now owns 8,675 shares in the company, valued at $4,237,390.50. The disclosure for this sale can be found here. In the last three months, insiders sold 8,852 shares of company stock valued at $4,313,962. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.